Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
10.07.2026 13:30
The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Is Boston Scientific (BSX) Undervalued As Clinical Results Lift Optimism Despite Watchman Concerns?
07.07.2026 05:28
Boston Scientific stock moves after clinical results and index changes Boston Scientific (BSX) has come into focus after promising clinical results coincided with multiple index removals and fresh analyst commentary on its Watchman device franchise and utilization trends. Shares recently moved higher, supported by the clinical update and reports of insider buying, even as analysts highlighted slower Watchman growth and trimmed their expectations. At the same time, Boston Scientific was...
Is Boston Scientific (BSX) Still One of the Best Stocks to Invest In After Jefferies Slashed Its Target?
06.07.2026 19:41
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 24, Jefferies analyst Matthew Taylor cut his price target on Boston Scientific Corporation (NYSE:BSX) to $67 from $100, while keeping a Buy rating on the stock. The analyst stated that a […]
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump
06.07.2026 17:07
Boston Scientific stock has fallen 56.5% over the past year, yet the valuation checks still lean toward the shares looking cheap relative to fundamentals and recent news has put a fresh spotlight on whether that gap is justified. The 56.5% one year share price decline raises the question of whether Boston Scientific is being priced for a much weaker outlook than its long term potential would suggest. On one side, the US$1.5b investment in MiRus and option to acquire its TAVR business may...
Fiserv And Lululemon Lessons Revisited: 5 Popular Stocks With Quant Sell Ratings
06.07.2026 13:30
Fiserv and lululemon crashes followed Quant Sell ratings. Click here to see 5 popular stocks that currently warrant investor caution.
Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growth
06.07.2026 08:40
Boston Scientific (BSX) offers a compelling value opportunity with a low P/E of 14.56, strong profitability, and solid growth, identified through ChartMill's "Decent Value" screen as a quality stock trading at a discount.
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know
02.07.2026 07:11
Boston Scientific is gearing up for earnings day, weighing a rocky stock run against Wall Street's stubbornly optimistic outlook.
Boston Scientific (BSX) Invests $1.5B in MiRus for Equity Stake and TAVR Acquisition Option
30.06.2026 11:14
Boston Scientific Corporation (NYSE:BSX) is one of the oversold tech stocks to buy now. On May 18, Boston Scientific invested $1.5 billion for a 34% equity stake in MiRus LLC, a company specializing in advanced biomaterials and medical implants. The deal includes an exclusive option for Boston Scientific to acquire MiRus’s proprietary TAVR system, which […]
Boston Scientific Corp (NYSE:BSX) Meets All Caviar Cruise Quality Criteria for Long-Term Investors
29.06.2026 10:00
Boston Scientific (BSX) passes the Caviar Cruise quality screen with 27% ROIC, 34.7% EBIT growth, and strong cash flow. A durable long-term investment candidate.
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
26.06.2026 14:48
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 9.5% over the past six months while the S&P 500 was up 6.2%.
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX)
25.06.2026 11:58
Boston Scientific Corporation (NYSE:BSX) is one of the Stocks Expected to Bounce Back According to Analysts. The stock has fallen more than 52% year-to-date, but the Street expects more than 65% upside from the current level. Recently, on June 16, TD Cowen analyst Josh Jennings maintained his Buy rating on Boston Scientific Corporation (NYSE:BSX) with […]
Piper Sandler Maintains Overweight Rating for Boston Scientific (BSX)
23.06.2026 15:06
Boston Scientific Corp. (NYSE:BSX) is one of the 10 oversold stocks offering high upside. On June 12, Matt O’Brien from Piper Sandler reduced the target price on Boston Scientific Corporation (NYSE:BSX) from $90 to $65, resulting in an adjusted upside potential of close to 45% at the current level. The analyst retained an Overweight rating […]
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
23.06.2026 13:30
According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
23.06.2026 10:00
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.07% on an annualized basis producing an average annual return of 13.28%. Currently, Boston Scientific has a market capitalization of
Cramer Passes On NioCorp And SoundHound — But Says One Stock Is 'Time To Buy'
22.06.2026 08:01
Jim Cramer recommends buying SOFI, and avoiding RIVN and BSX. He also says NIOBF is too speculative, but likes MP and INOD in the data engineering market.
Penumbra wins CE mark for Thunderbolt clot removal tech
18.06.2026 10:00
The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.
Why Did ADBE, CHWY, BSX Slump To 52-Week Lows Last Week?
15.06.2026 02:53
Adobe, Chewy, and Boston Scientific fell to 52-week lows on Friday after receiving multiple price target cuts from Wall Street analysts.
FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke
12.06.2026 15:34
Penumbra’s computer assisted vacuum thrombectomy platform uses aspiration for clot removal during acute ischemic stroke treatment.
Boston Scientific: The Market Is Pricing A Broken Compounder-We See A Reset One
12.06.2026 11:49
Boston Scientific stock plunged ~53% on guidance cuts and WATCHMAN/EP issues, but trades cheap vs. peers. Click here to read my analysis on Boston Scientific.
[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
10.06.2026 19:30
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gastrointestinal Endoscopy Devices Market size & share revenue was valued at approximately USD 11.6 Billion in 2025 and is expected to reach USD 12.2 Billion in 2026 and is expected to reach around USD 19.6 Billion by 2035, at a CAGR of 5.4% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are HOYA Corporatio